GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.05 (-3.54%)
Close on Nov 17, 2026Market cap $2.95MP/E –Yield –
GRI Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
GRI Bio's enterprise value was -$6.95M on Nov 11, 2026, against $179.02M a year earlier. Over the last 5 years it ranged from -$8.86M to $311.63B, with a median of $1.63B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$6.95M | -137.5% |
| 2025 | Dec 31, 2025 | $18.54M | -99.1% |
| 2024 | Dec 31, 2024 | $1.98B | -71.9% |
| 2023 | Dec 29, 2023 | $7.04B | -69.2% |
| 2022 | Dec 30, 2022 | $22.85B | -90.9% |
| 2021 | Dec 31, 2021 | $252.17B | – |
See a number that looks wrong?